Absorbed Dose per Injected Activity
| Site | Mean (n = 5) | Range |
| Adrenals | 0.027 | 0.020–0.031 |
| Bladder | 0.119 | 0.064–0.200 |
| Bone surfaces | 0.018 | 0.017–0.019 |
| Brain | 0.011 | 0.009–0.012 |
| Breast | 0.008 | 0.007–0.008 |
| Gallbladder | 0.017 | 0.015–0.019 |
| Gastrointestinal tract | ||
| Stomach | 0.023 | 0.020–0.027 |
| Small intestine | 0.028 | 0.023–0.035 |
| Colon | 0.015 | 0.013–0.016 |
| Upper large intestine | 0.015 | 0.014–0.016 |
| Lower large intestine | 0.014 | 0.013–0.016 |
| Heart | 0.018 | 0.014–0.019 |
| Kidneys | 0.029 | 0.022–0.034 |
| Liver | 0.046 | 0.031–0.056 |
| Lungs | 0.018 | 0.016–0.020 |
| Muscles | 0.010 | 0.009–0.010 |
| Esophagus | 0.009 | 0.008–0.011 |
| Ovaries | 0.015 | 0.014–0.017 |
| Pancreas | 0.031 | 0.028–0.036 |
| Red marrow | 0.025 | 0.023–0.026 |
| Skin | 0.007 | 0.006–0.007 |
| Spleen | 0.013 | 0.012–0.014 |
| Testes | 0.010 | 0.009–0.010 |
| Thymus | 0.009 | 0.008–0.010 |
| Thyroid | 0.013 | 0.012–0.013 |
| Uterus | 0.018 | 0.015–0.023 |
| Salivary glands | 0.019 | 0.010–0.037 |
| Remaining organs | 0.011 | 0.010–0.011 |
| Effective dose (mSv/MBq) | 0.023 | 0.019–0.028 |
Data are mGy/MBq. Doses were retrieved using IDAC 2.0. Residence times used for dose calculations are in Table 1.